Clinical Trial Update: A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating the activity of doxorubicin in AIDS-related Kaposi's sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Kaposi Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Sarcoma, Kaposi, HIV Infections | Phase 2 | Status: COMPLETED